Market intelligence
GDTCSector not reported
CytoMed Therapeutics Ltd insider activity
In the last 90 days, 1 corporate insider purchased $128,778 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $128,778
- Corporate buyers
- 1
- Latest transaction
- May 13, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
